Company · founded 1991
BioScience Laboratories (United States)
Bozeman, United States · biosciencelabs.com
- Citations, last 5 years
- 9
- Works, last 5 years
- 4
- h-index
- 37
- Scientists listed
- 0
- Grants since 2016
- 188
Grants received
2016–2021 · contract · N01
Comparison of Bivalent vs Pentavalent Subtype C Envelope HIV-1 Vaccine Efficacy Following Mucosal Virus Challenge
Ranajit Pal · BioScience Laboratories (United States) · funded by National Institutes of Health
2016–2019 · contract · N01
IGF::OT::IGF SMARTT BIOLOGICS PRODUCTION FACILITY (PF); BASE PERIOD; FY16; AMT $2,069,079; CAN 8470205
Phillip Ishikawa · BioScience Laboratories (United States) · funded by National Institutes of Health
2016–2020 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - SUPPORT FOR PRODUCTION AND TESTING OF ADC6-HIV GP140 AND ADC7-HIV GP140
Phillip Ishikawa · BioScience Laboratories (United States) · funded by National Institutes of Health
2016–2021 · contract · N01
Comparison of Bivalent vs Pentavalent Subtype C Envelope HIV-1 Vaccine Efficacy Following Mucosal Virus Challenge
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2016–2020 · contract · N01
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION OF HIV-1 ENVELOPE TRIMER PROTEINS
Phillip Ishikawa · BioScience Laboratories (United States) · funded by National Institutes of Health
2016–2021 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF GEO-D02 DNA DRUG PRODUCT
Timothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2016–2018 · contract · N01
SIMIAN VACCINE EVALUATION UNITS: Virus In Vivo Titration Study
Ranajit Pal · BioScience Laboratories (United States) · funded by National Institutes of Health
2016–2021 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF GEO-D02 DNA DRUG PRODUCT
Thomas Vancott · BioScience Laboratories (United States) · funded by National Institutes of Health
2016–2025 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - SUPPORT FOR PRODUCTION AND TESTING OF ADC6-HIV GP140 AND ADC7-HIV GP140
Phillip Ishikawa · BioScience Laboratories (United States) · funded by National Institutes of Health
2016–2020 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - SUPPORT FOR PRODUCTION AND TESTING OF ADC6-HIV GP140 AND ADC7-HIV GP140
Phillip Ishikawa · BioScience Laboratories (United States) · funded by National Institutes of Health
2016–2019 · contract · N01
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION FEASIBILITY EVALUATION OF TECHNOLOGY TO MODULATE PROTEIN EXPRESSION CELLULAR PATHWAYS
Thomas Vancott · BioScience Laboratories (United States) · funded by National Institutes of Health
2016–2018 · contract · N01
MATERIAL RECEIPT, STORAGE, SHIPPING AND INVENTORY
Glenn Swartz · BioScience Laboratories (United States) · funded by National Institutes of Health
2016–2017 · contract · N01
IGF::OT::IGF QUALITY ASSURANCE/ QUALITY CONTROL (QA/QC)
Ranajit Pal · BioScience Laboratories (United States) · funded by National Institutes of Health
2016–2028 · contract · N01
Production of cGMP Native Flexibly Linked HIV-1 Envelope Protein
Timothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2015–2024 · research · R44
Development of Molecular Diagnostic Test for Early Onset of Lyme disease
Barbara A. Body · BioScience Laboratories (United States) · funded by National Institutes of Health
2015–2022 · contract · N01
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2015–2021 · research · R44
Development of Molecular Diagnostic Test for Early Onset of Lyme disease
Steven E Schutzer · BioScience Laboratories (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
Task X16: Fecal Microbiota for Transplantation (FMT) Process Development
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2015–2021 · research · R44
Development of Molecular Diagnostic Test for Early Onset of Lyme disease
Barbara A. Body · BioScience Laboratories (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
Task X16: Fecal Microbiota for Transplantation (FMT) Process Development
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
Task X16: Fecal Microbiota for Transplantation (FMT) Process Development
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2014–2022 · contract · N01
Task X7: Malaria Vaccines Stability Study
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2014–2022 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF MHRP GP145 CLADE C PROTEIN
Nancy Lin · BioScience Laboratories (United States) · funded by National Institutes of Health
2014–2022 · contract · N01
Task 7: Malaria Vaccines Stability Study
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2014–2022 · contract · N01
Task 7: Malaria Vaccines Stability Study
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2014–2020 · contract · N01
Task X11: Product Development Plans and Feasibility Assessments
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2014–2022 · contract · N01
Task X6: Development of Candida Vaccines
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2014–2020 · contract · N01
Task X11: Product Development Plans and Feasibility Assessments
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2014–2020 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HCMV-TR3∆PP71 HIVGAG FOR CLINICAL TRIALS
Nancy Lin · BioScience Laboratories (United States) · funded by National Institutes of Health
2014–2020 · contract · N01
Task X11: Product Development Plans and Feasibility Assessments
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2014–2020 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HIV-1 gp120 PROTEIN
Nancy Lin · BioScience Laboratories (United States) · funded by National Institutes of Health
2014–2020 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HIV-1 gp120 PROTEIN
Nancy Lin · BioScience Laboratories (United States) · funded by National Institutes of Health
2014–2022 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - Production of Clade B, B.63521Δ11 gp120 Env Protein
Timothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2014–2021 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HCMV-TR3∆PP71 HIVGAG FOR CLINICAL TRIALS
Nancy Lin · BioScience Laboratories (United States) · funded by National Institutes of Health
2014–2020 · contract · N01
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HCMV-TR3∆PP71 HIVGAG FOR CLINICAL TRIALS
Nancy Lin · BioScience Laboratories (United States) · funded by National Institutes of Health
2014–2022 · contract · N01
Task X6: Development of Candida Vaccines
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2013–2021 · contract · N01
NIAID Preclinical Development Support - Production of HIV-gp120 Proteins
Thomas Vancott · BioScience Laboratories (United States) · funded by National Institutes of Health
2013–2022 · contract · N01
SVEU - Core Activities - Administrative and Technical Support
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2013–2022 · contract · N01
NIAID Preclinical Development Support - HIV-1 Envelope Protein Production
Timothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2013–2020 · contract · N01
Simian Vaccine Evaluation Unit - Core Activities: Administrative and Technical Support
Pal Ranajit · BioScience Laboratories (United States) · funded by National Institutes of Health
